Publicaciones en las que colabora con HOURIA BOULAIZ TASSI (41)

2014

  1. Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0)

    BioDrugs

  2. Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production

    Scientometrics, Vol. 98, Núm. 1, pp. 447-456

2013

  1. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing

    BioMed Research International, Vol. 2013

2012

  1. 5-Fluorouracil derivatives: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 22, Núm. 2, pp. 107-123

  2. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  3. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  4. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

    Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 (Springer Netherlands), pp. 157-171

2011

  1. Development of patents and clinical trials on regenerative therapy: Gene therapy

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194

  2. Nanomedicine: Application areas and development prospects

    International Journal of Molecular Sciences, Vol. 12, Núm. 5, pp. 3303-3321

  3. Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 134-141

  4. gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway

    International Journal of Molecular Sciences, Vol. 12, Núm. 11, pp. 7445-7458

2010

  1. Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation

    Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488

  2. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 1, pp. 69-78

  3. Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides

    Cell Biology International, Vol. 34, Núm. 9, pp. 917-924

  4. Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway

    Experimental Dermatology, Vol. 19, Núm. 4, pp. 363-371

  5. Release of muscle α-actin into serum after intensive exercise

    Biology of Sport, Vol. 27, Núm. 4, pp. 263-268

2009

  1. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo

    Journal of Molecular Medicine, Vol. 87, Núm. 9, pp. 899-911

2008

  1. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells

    International Journal of Oncology, Vol. 33, Núm. 1, pp. 121-127

  2. Experiencia docente en el marco del EEES: Anatomía Humana

    I Jornadas de trabajo sobre experiencias piloto de implantación del crédito europeo en las universidades andaluzas: libro de actas. Cádiz, del 19 al 21 de septiembre de 2006

  3. Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells

    British Journal of Dermatology, Vol. 159, Núm. 2, pp. 370-378